Azitra's Grant - IV Round

Azitra raised a round of funding on September 13, 2018. Investors include U.S. Department of Defense.

Azitra is developing a recombinant strain of skin-safe bacterium that secrete therapeutic proteins. These proteins are missing from the skin's microbiome when a person suffers from problems like eczem…

Articles about Azitra's Grant - IV Round: